Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Articles By This Author
Currency market today: Rupee falls 16 paise to 86.88 against US dollar in early trade
The rupee declined 16 paise to 86.88 against the US dollar in early trade on Tuesday amid a strengthening greenback, sustained FII outflows, and a
How will Germany’s Friedrich Merz build his coalition government?
German conservative leader Friedrich Merz spent the past two months excoriating the country’s Social Democrats — blaming them for a stagnating economy, uncontrolled illegal migration
Stock Market Holiday 2025: NSE, BSE closed on Feb 26 on account of Mahashivratri
Indian stock market will be closed on February 26, 2025, on account of Mahashivratri. Trading across equity, derivatives, securities lending and borrowings (SLB), currency and
52 Week Low Stocks Today on February 25, 2025: Tata Motors, Alembic Pharmaceuticals & others hit 52 week low today ;Check the full list here
52 Week Low Stocks Today on February 25, 2025: Shares of Tata Motors, Alembic Pharmaceuticals, Apollo Tyres, Aether Industries, Kajaria Ceramics hit their fresh 52
Tata Capital approves plan for initial public offering in India
Tata Capital Ltd is planning to go for an initial public offering (IPO) that will include a mix of new shares and an offer of
Small-cap crash: 20-stock portfolio strategy
After closing at a record high of 57,703 on 11 December 2024, the BSE SmallCap index has tumbled to 45,157 in just over two months,
Nifty Bank Prediction today – Feb 25, 2025: Index trades with a bearish tilt
Nifty Bank opened today’s session marginally higher at 48,691 versus yesterday’s close of 48,652. It is now hovering around 48,650. The advance/decline ratio of the
China’s superpower of scaling will spur DeepSeek’s competitive threat
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The writer is a geopolitics
Elevation Capital partner and COO Vivek Mathur quits
Elevation Capital’s Vivek Mathur, partner and chief operating officer (COO), has quit the venture capital firm after a 14-year stint at the company. He held
Biocon share price in focus after arm launches product in US for autoimmune diseases
Biocon share price rose by 2.5% during Tuesday’s trading session following the launch of a biosimilar product by its subsidiary, Biocon Biologics, aimed at treating